Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema

Athanassios K GiarmoukakisDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Styliani V BlazakiDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Georgios C BontzosDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Argyro D PlakaDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Konstantinos N SeliniotakisDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Larissa D IoannidiDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, Greece

Miltiadis K TsilimbarisDepartment of Ophthalmology, University Hospital of Heraklion, Heraklion, GreeceCorrespondence[email protected]

https://orcid.org/0000-0002-0130-1150

show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Athanasios Bezatis, Ioanna Georgou, John Dedes, Panagiotis Theodossiadis & Irini Chatziralli. (2022) Nepafenac in cataract surgery. Clinical and Experimental Optometry 105:3, pages 263-267.
Read now

Articles from other publishers (1)

Michał Orski & Maciej Gawęcki. (2021) Current Management Options in Irvine–Gass Syndrome: A Systemized Review. Journal of Clinical Medicine 10:19, pages 4375.
Crossref

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema

Citations (2)

Read on this site (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date